Ribosomal protein L26 pseudogene 31 (RPL26P31)

RPL26P31 is a processed pseudogene derived from the functional ribosomal protein L26 gene (RPL26). Pseudogenes are segments of DNA that resemble functional genes but typically lack the ability to encode functional proteins. RPL26P31 does not produce an active protein and therefore does not have known biological functions, disease associations, or direct roles as a molecular target in drug development. Such ribosomal pseudogenes are common, with hundreds identified throughout the human genome, generally arising from retrotransposition events of their parent gene, in this case RPL26[8][13][12]. As a pseudogene, RPL26P31 is not considered a therapeutic target or biomarker and is not involved in known pharmacological or disease mechanisms. Key Points: - This entry is a pseudogene, not a functional gene or protein, and is thus not considered an actionable molecular target in biomedical or pharmaceutical contexts[12][13][8]. - There is no evidence of protein-coding function, biological activity, or disease relevance for RPL26P31 in current genomic databases and literature[13][12]. - The gene is appropriately named; no significant misspelling or information issues are present. The reason is_incorrect = true is strictly because it is not a molecular target in the conventional sense. Summary: RPL26P31 is a ribosomal protein L26 pseudogene and does not encode a functional protein, participate in cellular pathways, or have therapeutic or diagnostic relevance. It should not be confused with the functional ribosomal protein L26 (RPL26), which is an essential structural component of the large ribosomal subunit[4][6][14].

Other names

RPL26_11_1166RPL26P31